Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelaic acid iontophoresis versus topical azelaic acid cream in melasma
2008-003792-52Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Azelaic acid in melasma (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Change in MASI score from baseline to 12 weeks and Change in colorimetry from baseline to 12 weeks. Started Apr 2009; status: completed.
02
Drugs
Azelaic acid
03
Conditions
melasma
Beyond the preview
Go deeper on 2008-003792-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003792-52.